TABLE 2.
AWME3 (mg/mL) | IZD (mm) |
|||||
KP ATCC BAA-2473 |
KPM9 |
KPi1627 |
||||
12 h | 24 h | 12 h | 24 h | 12 h | 24 h | |
20 | 22.8 ± 0.47 | 19.72 ± 0.51 | 18.7 ± 0.52 | 16.52 ± 0.74 | 14.83 ± 0.49 | 14.23 ± 0.35 |
10 | 14.7 ± 0.26 | 13.88 ± 0.35 | 13.6 ± 0.56 | 12.98 ± 0.39 | 11.6 ± 0.34 | 10.5 ± 0.37 |
5 | 12.73 ± 0.21 | 10.78 ± 0.33 | 10.25 ± 0.4 | 9.48 ± 0.28 | 9.43 ± 0.24 | 8.67 ± 0.24 |
2.5 | 11.17 ± 0.24 | 9.25 ± 0.54 | 8.1 ± 0.33 | 7.67 ± 0.25 | 7.45 ± 0.32 | 7.18 ± 0.19 |
1.25 | 8.9 ± 0.45 | 8.06 ± 0.52 | 7.15 ± 0.27 | 6.63 ± 0.2 | 6.86 ± 0.19 | 6.5 ± 0.23 |
P.C (DOX) | 18.48 ± 2.3 | 18.1 ± 1.2 | 19.18 ± 0.8 | 18.62 ± 0.35 | 18.68 ± 0.9 | 17.43 ± 0.8 |
N.C | ND | ND | ND | ND | ND | ND |
ND, not determined; N.C, negative control; P.C (DOX), positive control (doxycycline) at a concentration of 600 μg/ml (30 μg/disk).